Philips' Digital Transformation at Year Five: A Strategic Shift Toward Integrated Health Technology Solutions

As early as 1996, digital visionary Nicholas Negroponte foresaw today’s digital era in his book *Being Digital*, which posits that “being digital” is a new mode of existence in modern society based on information technology. The healthcare sector is no exception to this prophecy.

Most life sciences startups born in the emerging era have digitalization embedded in their DNA. However, for technology companies with a deep historical legacy, digitalization signifies transformation, entailing internal resistance to change, unpredictable growing pains, and unknown risks. Consequently, “passive transformation” has become the norm; by the time many large enterprises adopt this strategy, they may already lag several years behind the market, burdened by entrenched issues that are difficult to reverse.

Philips is a prime example of a company that has successfully completed its digital “proactive transformation.” Over its 130-year history, Philips has continuously expanded its footprint. Starting as a manufacturer of carbon-filament light bulbs, the company gradually built multiple business portfolios, including lighting, consumer electronics, home appliances, and healthcare systems. However, after the turn of the millennium, it continually adjusted and streamlined its traditional business lines. Effective January 1, 2008, the company simplified its organizational structure and established three core divisions: Healthcare, Lighting, and Lifestyle.

In the second decade of the 21st century, Philips continued to undergo internal adjustments, boldly breaking away from the increasingly homogenized “red ocean” of products and precisely focusing on high-potential sunrise industries, thereby entering a value-oriented “blue ocean.”

To more precisely focus on “Health Technology,” Philips has continuously increased the proportion of its Health Technology business portfolio through a series of divestitures and mergers and acquisitions (including the divestiture of its Lighting and Domestic Appliances businesses). This strategy has established four core segments: Healthy Living, Precision Diagnosis, Image-Guided Therapy, and Connected Care. By integrating resources to develop integrated systems, intelligent devices, software, and services as comprehensive solutions for the market, Philips has gradually shaped its current operational landscape.

A set of data may illustrate Philips’ transformation achievements: Since its transformation in 2016, Philips has achieved annual performance growth of 4–6%, with its profit margin increasing from 5% in 2011 to 13% in 2020; its stock price also rose from €14 in December 2011 to €51 in April 2021.

From its initial foray into healthcare to its deep engagement in the sector, Philips’ strategic decisions have been driven by its analysis of global trends. In brief, these trends can be summarized into four key areas: “value-based healthcare as the primary driver,” “fully connected chronic disease management,” “shifting from passive to proactive care,” and “transitioning from equipment sales to service-oriented models.” These four trends are applicable to all companies operating in the digital health industry.

Trend 1: “Value-Based Healthcare as the Primary Driver” is policy-driven, led by healthcare regulatory authorities and implemented by healthcare institutions. Under the DRG payment system, healthcare institutions must shift their focus from pursuing “volume” to pursuing “quality” to achieve greater revenue, thereby reducing costs. Under the tiered diagnosis and treatment system, healthcare institutions at different levels assume responsibility for treating different conditions based on disease severity and treatment complexity, optimizing the allocation of medical resources; this enhances both the quality and accessibility of services.

“Fully Connected Chronic Disease Management” is an extension of value-based healthcare, requiring collaborative efforts between hospitals and patients. Amid the aging population trend, the number of patients with chronic diseases continues to rise, imposing a significant burden on the medical insurance system due to sustained high expenditures. Therefore, the chronic disease management system requires lower-cost care and smarter connectivity between in-hospital and out-of-hospital settings, so as to optimize the quality of chronic disease management within given healthcare spending constraints.

"Proactive Engagement in Passive Care" Is a New Hallmark of the Era. Today, consumers’ health awareness has surged, and they are increasingly inclined to take an active role in managing their own and their families’ health. This means that life sciences companies should serve as “connectors,” shifting their focus from diagnosis and treatment toward prevention, thereby aligning with emerging needs under this new paradigm.

“Shifting from Equipment Sales to Services” is the response of life sciences companies to changing commercial trends. As medical institutions at all levels become increasingly well-equipped, how to provide high-value-added medical services based on these devices has become a key consideration for major medtech manufacturers seeking new business growth.

Overall, these four trends have placed high demands on the “digitalization” of the healthcare sector and provided additional impetus for Philips’ transformation. To respond to developments in this new landscape, Philips has embarked on a transformation centered on three key areas: “products,” “organization,” and “strategy.”

Whether in the realm of healthy living or medical equipment, Philips excels at optimizing its products to the utmost within specific scenarios. For instance, the Philips MRC800 X-ray tube has a standard lifespan of 2 million seconds, approximately ten times that of conventional tubes. The Philips Ingenia Ambition MRI system employs BlueSeal technology, ushering MRI equipment into a new era by reducing the liquid helium requirement for superconducting magnets from 1,500–2,000 liters to just 7 liters, thereby fundamentally eliminating the risk of quenching. However, in healthcare services, perfect but isolated solutions (which suffer from data silo issues) can no longer meet user demands. While retaining the advantages of its high-quality equipment, Philips needs to extend its services downstream. To this end, Philips has initiated product transformation along three strategic directions.

As a medical device manufacturer traditionally focused on the R&D, production, and sales of individual products, Philips has been able to provide a wide range of equipment in the professional healthcare sector—including ultrasound systems, CT scanners, MR scanners, patient monitors, angiography systems, and AEDs—thereby meeting the procurement needs of hospital equipment departments.

However, with the transformation of the healthcare system, Philips’ strategy is to position its core focus on the entire “healthcare journey,” spanning “healthy lifestyles,” “prevention,” “diagnosis,” “treatment,” and “home care.” Leveraging its comprehensive business model that covers both consumer-to-business (C2B) and business-to-business (B2B) segments, Philips aims to provide integrated solutions encompassing smart devices, systems, software, and services for consumers and clients.

This product differs from traditional offerings by shifting away from focusing on a single “point” within the diagnosis and treatment process. Instead, it connects the patient’s entire clinical journey with their overall health and wellness, delivering personalized solutions to empower patients in managing their own health.

Under the traditional model, marketing and sales personnel typically approach customer communications by focusing on the features, advantages, and pricing of individual products, aiming to meet customers’ hardware needs for products or equipment. However, as companies transition toward providing solutions, they are required to shift their mindset. They must focus on the segmented demands within China’s complex healthcare system and deliver comprehensive solutions that integrate devices, software, systems, and services, tailored to specific clinical scenarios and clinical pathways.

To this end, Philips has mapped out the challenges associated with each disease across clinical pathways and the entire patient lifecycle, integrating relevant data and information to imbue meaning into data generated by general consumers or patients as well as healthcare professionals. The development of Philips’ medical artificial intelligence (AI) serves as a prime example. In the past, medical devices such as CT scanners were primarily positioned as imaging tools, focused on the generation and acquisition of imaging data. With the integration of AI, Philips has fused these capabilities with advanced data analytics, thereby enhancing the analytical functions of imaging equipment. Consequently, its application scenarios have naturally expanded from radiology departments to broader clinical specialties.

Let’s further discuss the Smart ICU Solution. Centered on the “patient,” this solution enables seamless, end-to-end data management across the entire care journey—from admission, diagnosis, and therapeutic nursing to outcomes. It integrates information exchange, facilitates inter-departmental connectivity within the hospital, and even establishes interoperability between in-hospital and out-of-hospital settings. This approach yields comprehensive, continuous, high-quality, and systematic patient data, transforming such data into actionable insights to enhance the work efficiency of clinicians and nurses.

With the continuous advancement of digital and interconnected technologies, people’s lifestyles have undergone disruptive changes. In addition to traditional physical “things,” people are increasingly relying on intangible means such as software systems and applications to access entirely new services.

Over the past few years, Philips has prioritized software development and artificial intelligence as key strategic focus areas, investing nearly €1.9 billion annually in research and development. More than 50% of its R&D personnel are dedicated to software development and related fields such as big data and AI. Key research topics include natural language processing, big data mining and analysis, construction of structured clinical databases, image recognition, imaging-assisted diagnosis, interventional therapy, genomics, chronic disease management, home care, and cloud platform solutions.

Philips’ IntelliSite Digital Pathology Solution is the first digital pathology system approved by the FDA for clinical diagnosis, also receiving approvals from the NMPA and CE marking, thereby bringing a certain degree of disruption to pathology departments.

Traditional physical glass slides require manual distribution, which is time-consuming, error-prone, and inconvenient for sharing. Digitizing pathological clinical diagnosis can effectively overcome these drawbacks, optimize resource allocation, and significantly improve the efficiency and quality of diagnoses in pathology departments. Meanwhile, Philips enables the digitization of clinical diagnosis through a comprehensive solution covering the entire diagnostic workflow. Its high-speed and stable scanning system, along with an efficient and seamless software platform, are specifically designed to meet the high-throughput demands of clinical settings. The IT architecture integrates seamlessly into existing hospital workflows, and its image quality is supported by results from large-scale multicenter studies.

The synchronized transformation across three dimensions hinges on the integrative efforts of entrepreneurs. Since initiating this transformation, Philips has been striving to build a comprehensive healthcare ecosystem, achieving integration from single points to entire workflows and transcending from hardware-only offerings to integrated hardware, software, and service solutions. To this end, numerous medical technology companies have joined Philips’ ecosystem. Collaborations such as the integration of Philips’ CT with Shukun Technology’s CTA (structured assessment of coronary arteries) and Keya Medical’s CT-FFR (assessment of blood supply function); the partnership with Elsevier to establish clinical decision support and clinical pathway platforms, thereby promoting the comprehensive development of medical practice, education, and research; and the cooperation with Boshijiankang to integrate its automatic radiotherapy target delineation system with the Imaging2Plan system, all serve to jointly drive ecosystem expansion.

If R&D, production, and sales are likened to the limbs of an enterprise, then organization, culture, and talent are the blood that sustains their operation. In Philips’ view, only by implementing comprehensive digital transformation across organization, culture, and talent can a company achieve true enterprise transformation.

Over the past five years, Philips has successively established organizational units such as the Solutions Center, China Digital Innovation Center, and Clinical and Technology Solutions Department, leveraging organizational digital transformation to drive the company’s overall digital transformation.

Philips established its Solutions Center in 2016, during the early stages of its corporate transformation. Within the healthcare industry, leveraging a Solutions Center as the core driver for organizational restructuring represents a breakthrough approach. The center frequently addresses critical industry questions, such as: As China actively promotes the development of smart hospitals, what language should sales professionals use to present these solutions to hospital directors? How can clinically savvy medical experts help hospitals analyze ways to improve imaging diagnostic outcomes? How can software and cloud-based systems be utilized to build digital platforms that enhance the speed and accuracy of diagnosis and treatment? Many digital health companies transitioning from the internet sector tend to consider these issues only after completing product design. In contrast, Philips’ proactive questioning serves as a beacon, guiding and safeguarding the product design and R&D processes.

Aligned with Philips’ digital innovation transformation strategy, the Philips Research China established the “China Digital Innovation Center” in 2016 to provide early-stage planning for Chinese users purchasing digital products and to enable localized system delivery. The uniqueness of China’s healthcare market necessitates that multinational enterprises adopt customized designs tailored to local realities. Only products capable of meeting China’s diverse and localized needs can truly take root in the country—this is the core mission of the China Digital Innovation Center.

Beyond organizational structure lies talent. Centered on transformation, the company has provided relevant teams with systematic knowledge consolidation, skills training, and barrier-breaking communication through “Sales Excellence,” “Marketing Excellence,” and “Technological Innovation Excellence,” thereby helping employees enhance their personal leadership capabilities.

In terms of cultural transformation, Philips strives to create a workplace characterized by Inclusion & Diversity, an environment that fosters innovation, enhanced performance, and employee satisfaction. By cultivating an inclusive work environment, Philips brings together a diverse pool of multidisciplinary talent to address critical healthcare challenges and collaborates with medical institutions to help them overcome their most significant obstacles. The company remains committed to promoting equality in the workplace, ensuring that each individual’s uniqueness is respected and valued, thereby fostering a sense of value alignment and belonging among its employees.

After five years of transformation, Philips’ digital overhaul has begun to yield results: bolstered by numerous partners, the company has seen significant growth in both revenue and profits. However, in terms of the broader landscape, Philips has only taken the first step toward building a competitive healthcare ecosystem.

On one hand, Philips is not the only player undergoing digital transformation. While Philips aims to build an ecosystem, other healthcare giants share the same ambition. Therefore, Philips must consider what core advantages the future healthcare ecosystem should possess—a value proposition that current products alone cannot convey.

On the other hand, due to the relatively low overall development level of digital health, although the ecosystems of major enterprises have taken shape, few digital companies are able to join these ecosystems, resulting in a lack of competitive vitality. Therefore, Philips must continue its previous incubation strategy, fostering mutual growth with partners while undergoing its own transformation. This is an essential path to building sustainable ecosystem growth.

Therefore, strategy is key to the next step in digital transformation. How can more complementary enterprises be cultivated? How can high-quality enterprises be attracted? How can a vibrant ecosystem be built? Philips may address these questions one by one in the near future.